← Back
$DMRA All transactions

Damora Therapeutics, Inc.

A

$ Value

$0

Shares

37,313

Price

$0

Filed

Mar 25

Insider

Name

Fairmount Funds Management LLC

Title

CIK

0001802528

Roles

Director 10% Owner

Transaction Details

Transaction Date

2026-03-23

Code

A

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

37,313

Footnotes

This option represents a right to purchase shares of common stock of the Issuer. This option will vest in equal monthly installments through March 23, 2029, subject to the Reporting Person's continued service to the Issuer on each such vesting date. | Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II LP ("Fund II") and Fairmount Healthcare Co-Invest V L.P. ("Co-Invest"). Peter Harwin and Tomas Kiselak are the managers of Fairmount. Under Mr. Harwin's arrangement with Fairmount, Mr. Harwin holds the option for one or more investment vehicles managed by Fairmount (each, a "Fairmount Fund"). Mr. Harwin is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Filing Info

Accession No.

0001193125-26-124471

Form Type

4

Issuer CIK

0001800315

Fairmount Funds Management LLC's History

Date Ticker Type Value
2026-03-31 COGT C
2026-03-31 COGT $242.6M
2026-03-31 COGT C $0
2026-03-31 ZBIO $3.0M
2026-03-23 DMRA A $0
2026-02-09 GLTO M $0
2026-02-09 GLTO M $0
2026-02-09 GLTO M $0
2026-02-09 GLTO M $0
2026-01-22 APGE $133.5M

Other Insiders at DMRA (90d)

Insider Bought Sold Last
Landsittel Michael 2026-03-23
Jarrett Jennifer
See Remarks
2026-03-30
Turtle Cameron 2026-03-23
Fairmount Funds Management LLC 2026-02-09
Winslow Garrett
General Counsel
2026-03-23
CAIN CHRISTOPHER W. 2026-03-23
Bruno Julianne 2026-03-23
Sattarzadeh Sherwin
Chief Operating Officer
2026-01-05